TCRX Competitors & Alternatives
Compare Tscan Therapeutics Inc with similar stocks in the same industry
Biotechnology
TCRX
Main Stock$0.78
Tradestie Score
44
Market Cap
$118.60M
Revenue Growth
-0.7%
Analyst Upside
+669.7%
Top Competitors
242 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
ABOS
Acumen Pharmaceuticals, Inc. Common Stock
|
$3.16
|
$106.00M | - | 40 | Compare |
|
OVID
Ovid Therapeutics Inc. Common Stock
|
$2.80
|
$97.42M | - | 44 | Compare |
|
HOWL
Werewolf Therapeutics, Inc. Common Stock
|
$0.87
|
$89.17M | - | 36 | Compare |
|
PRLD
Prelude Therapeutics Incorporated
|
$6.63
|
$85.47M | - | 43 | Compare |
|
ENTX
Entera Bio Ltd. Ordinary Shares
|
$3.23
|
$84.52M | - | 45 | Compare |
|
RLMD
Relmada Therapeutics, Inc. Common Stock
|
$4.63
|
$71.69M | - | 48 | Compare |
|
ARTV
Artiva Biotherapeutics, Inc. Common Stock
|
$10.93
|
$71.32M | - | 47 | Compare |
|
IMMX
Immix Biopharma, Inc. Common Stock
|
$13.66
|
$67.94M | - | 41 | Compare |
|
IPSC
Century Therapeutics, Inc. Common Stock
|
$2.07
|
$43.18M | - | 54 | Compare |
|
INAB
IN8bio, Inc. Common Stock
|
$1.28
|
$10.26M | - | 33 | Compare |
More TCRX Analysis
Data updated: Aug 23, 2026 | Industry: Biotechnology (SIC 2836)
242 stocks in this industry